Mutations in NFE2L2 exon 2 were already described as a common mechanism of NRF2 hyper‐activation in cancer because alterations in this exon lead to an aberrant Neh2 domain and consequently to NRF2 stabilization in the cytoplasm by escaping KEAP1‐regulated degradation.39 This evidence concerns the gene NFE2L2 and cancer.